Therapeutic Education of the Patients Diabetics Imprisoned at the Paris Jail

NCT02159417 | Completed

• 1 other identifier: 2013-A00704-41
• Study Type: interventional
• Target: 22
• Locations: 1 country
• Sites: 2

Brief Summary

A lot of data show that therapeutic education is beneficial for diabetic patients. In the French jails, there are very few programs of therapeutic education while this population is usually precarious with no access at care sector before the jail. The purpose of this study is to determinate if the therapeutic education of the diabetic patients is possible in the Paris jail "La Santé".

Conditions

Type 1 or 2 Diabetes

Keywords

Evolution of the sport, HbA1C, IMC

Outcome Measures

Primary Outcomes (1)

• The feasibility of the application of the action ETP in the MAPLS

  Rate of participation to at least two therapeutic workshops

  3 months

Secondary Outcomes (4)

• Estimation of the satisfaction of the prisoners and the nursing after participation of educational therapeutic workshops

  3 months

• biomedical parameters: HbA1c and IMC

  3 months

• The number of hours all in all, for all the activities ETP and by categories of tasks

  3 months

• The satisfaction of the staffs as for the implementation and the realization of the experiment

  3 months

Study Arms (1)

Therapeutic Education

EXPERIMENTAL

Intensive training individual or collective teaching

Other: Therapeutic Education

Interventions

Therapeutic Education OTHER

Realization of a consultation of educational diagnosis, followed by the participation for every patient to 4 educational collective workshops therapeutic: * Knowledge of the disease * Food * Physical Activity and care of feet * The therapeutics

Also known as: Intensive training individual and collective teaching

Therapeutic Education

Eligibility Criteria

• Age: 18 Years+
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Male patient detained in the MAPLS of more than 18 years
• Patient prisoner in the MAPLS for more than 15 days
• Patient follow-up for a diabetes of type 1 or type 2
• Patient informed about the study and not having opposed to this one
• Patient taken out of the disciplinary district which had previously been included for this motive

You may not qualify if:

• Patient considered incapable by the investigator to follow an ETP program
• Patient having a bad understanding of the spoken French language
• Patient prisoner in the district of isolation
• Patient prohibition to communicate with another prisoner already registered on the session to come

Sponsors & Collaborators

• Assistance Publique - Hôpitaux de Paris: lead
• URC-CIC Paris Descartes Necker Cochin: collaborator

Study Sites (2)

Hôpital COCHIN

Paris, 75014, France

Location

Maison d'Arrêt Paris La Santé (MAPLS)

Paris, 75014, France

Location

Study Officials

• Benjamin SILBERMANN, MD, PhD

  Assistance Publique - Hôpitaux de Paris

  STUDY DIRECTOR

• Laura HARCOUET, Pharm D

  Assistance Publique - Hôpitaux de Paris

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 5, 2014
• First Posted: June 9, 2014
• Study Start: November 1, 2013
• Primary Completion: October 1, 2014
• Study Completion: February 1, 2015
• Last Updated: November 20, 2025

Record last verified: 2025-09

Locations

FR (2)